Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Laboratories Acquires Single-Cell Analysis Firm Celsee

NEW YORK – Bio-Rad said on Thursday that it has acquired Ann Arbor, Michigan-based Celsee, which offers instruments and consumables for isolating, detecting, and analyzing single cells.

Financial terms of the acquisition were not disclosed.

Celsee's Genesis system enables users to isolate and analyze single cells for applications including cytometry, transcriptomics, multi-omics, rare-cell enrichment and enumeration, and immune monitoring.

The system can scale from hundreds of thousands to millions of cells for genomic and proteomic applications. It can also enrich for or monitor circulating tumor cells to determine disease progression and therapeutic response.

Celsee is currently embroiled in patent litigation with 10x Genomics, which has alleged patent infringement, unfair competition, false advertising, and related claims against Celsee in the US District Court for the District of Delaware. In late March, Celsee filed an answer and counterclaims to a second amended complaint by 10x.

Meanwhile, Herculese, California-based Bio-Rad itself remains involved in multiple patent lawsuits with 10x Genomics.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.